Legal status in the United States

Is PT-141 legal?

Read at FDA, DEA and WADAPublished by PepVault

PT-141 (bremelanotide) is FDA-approved (Vyleesi, first in 2019), is not a federally controlled substance, and is not named on WADA’s Prohibited List, as of November 18, 2026.

PT-141 at a glance

CheckStatus, read Nov 18, 2026
FDA approvalApproved (Vyleesi, 2019)
CompoundingComponent of an approved drug (503A condition)
DEA scheduleNot controlled
Sport (WADA)Not named on the list

FDA approval

Bremelanotide, sold on the street as PT-141, is FDA-approved as Vyleesi, since 2019, for one use in premenopausal women.

  • Vyleesi (injection)

    Approved for low sexual desire that causes marked distress (acquired, generalized hypoactive sexual desire disorder) in premenopausal women; its label says it is not for men or to enhance sexual performance. NDA 210557, first approved June 21, 2019.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Compounding

Bremelanotide is the active ingredient of an FDA-approved drug (Vyleesi). FDA’s page on bulk drug substances gives three conditions under section 503A for a substance a pharmacy compounds from, and one of them is being a component of an FDA-approved drug product; the 503A and 503B bulks lists don’t name bremelanotide.

The source: “Are components of FDA-approved drug products if an applicable USP or NF monograph does not exist”

DEA schedule

It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

Sport (WADA)

The 2026 Prohibited List doesn’t name bremelanotide, and S0, the class for unapproved substances, doesn’t reach an approved drug.

What this means and doesn’t

This page reports what the agencies’ own pages said about PT-141 in the United States when we read them on November 18, 2026. These are records of regulators, not study evidence; for what the research shows, see the compound page.

It is not legal advice, and it doesn’t cover state laws or other countries, whose rules differ. Agencies change their lists, so each fact carries its date and a link to the page it came from.

Questions

  • Is PT-141 FDA approved?

    Bremelanotide, sold on the street as PT-141, is FDA-approved as Vyleesi, since 2019, for one use in premenopausal women.

  • Is PT-141 a controlled substance?

    It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

  • Is PT-141 banned in sport?

    The 2026 Prohibited List doesn’t name bremelanotide, and S0, the class for unapproved substances, doesn’t reach an approved drug.

  • What does FDA say about compounding PT-141?

    Bremelanotide is the active ingredient of an FDA-approved drug (Vyleesi). FDA’s page on bulk drug substances gives three conditions under section 503A for a substance a pharmacy compounds from, and one of them is being a component of an FDA-approved drug product; the 503A and 503B bulks lists don’t name bremelanotide.

Read next

Track it in the app

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo